Mission
USP'S MISSION IS TO IMPROVE GLOBAL HEALTH THROUGH PUBLIC STANDARDS AND RELATED PROGRAMS THAT HELP ENSURE THE QUALITY, SAFETY, AND BENEFIT OF MEDICINES AND FOODS.
Public Charity
UNITED STATES PHARMACOPEIAL CONVENTION
UNITED STATES PHARMACOPEIAL CONVENTION is a nonprofit organization categorized as Public Charity based in ROCKVILLE, MD. Its most recent IRS filing (2025) reports revenue of $357.7M, expenses of $333.6M, total assets of $788.7M. Imperigo tracks 8 reported grant relationships connected to this organization totaling approximately $1.5M.
EIN: 131656692
ROCKVILLE, MD
Research Institutes & Public Policy Analysis
NTEE: E05
Latest filing: 2025
Total Revenue$357.7M
Total Expenses$333.6M
Total Assets$788.7M
Grant Records8
Funding Total$1.5M
Filing Years2021–2025
Where $100 goes at United States Pharmacopeial Convention
How United States Pharmacopeial Convention divides every $100 it spends, from its own Form 990 filings, averaged across 7 years.
$69
Programs
the work itself
$31
Management
running the organization
$0
Fundraising
none reported
No fundraising costs are reported. That often means fundraising runs through a separate affiliated organization that files its own return.
Inside the $69 for programs
$60
Compendial activities
$8
Non-compendial activities
$1
Allied compendial activities
Source: Form 990 filings with the IRS, latest fiscal year 2025. Shares are from the organization's reported expenses. Data by Imperigo; not affiliated with the IRS.
Sample Grants Received
OPERATIONAL SUPPORT
$44,327
OPERATIONAL SUPPORT
$169,332
OPERATIONAL SUPPORT
$476,593
FDA subgrant awards for pharmaceutical research
$165,333
OPERATIONAL SUPPORT
$261,783
Showing up to 5 of 8 total records — full history available with membership.
Officers & Directors
SVP, LEGAL, STRATEGY & PEOPLE
Amanda D Cowley
SECRETARY & SVP GLBL EA
Anthony P Lakavage
SVP, GLOBAL LAB & TECHNICAL OPS
Bruk Alemayehu
CHIEF EQUITY OFFICER
Debra J Perez
CONVENTION PRESIDENT
Dennis E Doherty Md
SVP, GBL HEALTH & MANUFACTURING SVCS
Emily M Kaine
Officer compensation and complete director data available with membership.
Top Grant Purposes
Financial Trends
| Year | Revenue | Expenses | Assets |
|---|---|---|---|
| 2025 | $357.7M | $333.6M | $788.7M |
| 2024 | $353.7M | $330.3M | $750.8M |
| 2023 | $346.3M | $313.3M | $701.8M |
| 2022 | — | — | $655.7M |
| 2021 | $331.1M | $286.0M | $667.9M |
Between 2021 and 2025, reported annual revenue grew from $331.1M to $357.7M (+8%), with total assets most recently reported at $788.7M.
Interactive year-over-year charts and full filing details available with membership.